Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares

NCT01459796 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: Rilonacept
DRUG: Placebo
DRUG: Allopurinol

Sponsor

Regeneron Pharmaceuticals